Vikrant Verma | Pharmaceutical Chemistry | Best Academic Researcher Award

Published on | Editorial Board by World Top Scientists

Best Academic Researcher Award

Vikrant Verma — Subharti University, India

Vikrant Verma
Affiliation Subharti University
Country India
Scopus ID 57213651680
Documents 20
Citations 71
h-index 4
Subject Area Pharmaceutical Chemistry
Event World Top Scientist Awards
ORCID 0000-0002-1994-9641

Vikrant Verma is a pharmaceutical researcher and academic affiliated with Subharti University in Meerut, Uttar Pradesh, India. His documented research activities cover pharmaceutical chemistry, pharmacology, drug formulation, analytical methods, medicinal chemistry, and pharmaceutical and biomedical applications. The available ORCID record identifies an academic appointment at the Kharvel Subharti College of Pharmacy and records research works across multiple publication years.[1]

Abstract

Vikrant Verma’s documented academic profile reflects research activity within pharmaceutical chemistry and related biomedical disciplines. His recorded publications address medicinal compounds, pharmaceutical formulations, analytical procedures, pharmacological mechanisms, and emerging therapeutic technologies. The ORCID record lists 25 works, including journal articles and book chapters, while the supplied profile records 20 documents, 71 citations, and an h-index of 4. Recent works include studies of drug discovery, cardiovascular therapeutics, herbal compounds, radiopharmaceuticals, and wearable healthcare technologies. [1]

Keywords

Vikrant Verma, pharmaceutical chemistry, medicinal chemistry, pharmacology, drug formulation, pharmaceutical analysis, drug discovery, therapeutic research, Subharti University, academic researcher, pharmaceutical research.

Introduction

Pharmaceutical chemistry integrates chemical principles with the discovery, characterization, formulation, and evaluation of compounds relevant to medicine. Verma’s documented publication record demonstrates involvement in this broad research environment through original studies and review-oriented contributions. His work includes conventional pharmaceutical formulation and analytical method development alongside research addressing contemporary pharmacological and biomedical questions. The range of recorded topics provides a basis for describing his academic activity across interconnected areas of pharmaceutical science. [2]

Research Profile

The ORCID record identifies Vikrant Verma with Swami Vivekanand Subharti University, Meerut, and an academic role at the Kharvel Subharti College of Pharmacy. His listed works extend from earlier pharmaceutical and phytochemical research to recent investigations and reviews in pharmacology and drug development. Examples include research on quinolone derivatives, piracetam derivatives, fluconazole analysis, sustained-release formulations, and herbal interventions. More recent publications address artificial intelligence in drug discovery, endothelial dysfunction, quercetin, radiopharmaceuticals, and wearable devices. [3]

Research Contributions

The publication record indicates contributions spanning pharmaceutical formulation, medicinal chemistry, analytical methodology, pharmacological review, and translational biomedical subjects. His documented studies include sustained-release formulations involving reserpine and polythiazide, method development involving antihypertensive agents, and synthesis and evaluation of heterocyclic compounds. Other publications examine herbal extracts, traditional medicines, and therapeutic mechanisms relevant to contemporary pharmaceutical research. Together, these works illustrate a research profile connecting laboratory-oriented pharmaceutical chemistry with broader drug-development and therapeutic themes. [4]

Publications

Selected recent publications include “Mechanistic pharmacology of TCM-derived bioactive compounds in Alzheimer’s disease,” published in Pharmacological Research – Modern Chinese Medicine, and “Mechanistic Insights, Structure-activity Relationships, and Safety Profile of Mitragyna speciosa Alkaloids.” Other recorded works include “Theranostic applications of PSMA-targeted radiopharmaceuticals,” “Quercetin and the gut-brain axis,” and “Artificial intelligence and machine learning in drug discovery.” The record also contains earlier articles concerning fluconazole analysis, piracetam derivatives, thiadiazole derivatives, and phytotoxin characterization. [5]

Research Impact

The supplied bibliometric profile reports 20 documents, 71 citations, and an h-index of 4. These indicators provide quantitative information about the documented publication and citation record associated with the researcher. Citation counts and h-index values can change as indexing databases update their records and therefore represent measurements at a particular point in time. The ORCID record further provides a structured overview of the researcher’s works and their associated publication metadata.[4]

Award Suitability

The Best Academic Researcher Award profile can be supported by documented academic affiliation, a defined pharmaceutical chemistry subject area, and a record of scholarly publications. Verma’s ORCID record demonstrates continued publication activity across pharmaceutical and biomedical research topics, including several works published during 2025 and 2026. His Scopus identifier and supplied bibliometric indicators provide additional mechanisms for documenting the research record. The evidence presented here can therefore serve as a factual academic profile for consideration within the World Top Scientist Awards event.[4]

Conclusion

Vikrant Verma’s documented research portfolio encompasses multiple areas within pharmaceutical chemistry and related biomedical science. His publications demonstrate activity in formulation, medicinal chemistry, pharmacological research, analytical methods, and emerging therapeutic applications. The available record combines bibliometric information with identifiable publications and persistent researcher identifiers. These documented elements provide a structured basis for presenting his academic research profile in connection with the Best Academic Researcher Award.[4]

References

  1. ORCID. (2026). Vikrant Verma: ORCID record and works. ORCID.
    https://orcid.org/0000-0002-1994-9641
  2. Verma, V., & Kumar, D. (2026). Mechanistic insights, structure-activity relationships, and safety profile of Mitragyna speciosa alkaloids. Current Bioactive Compounds. DOI: 10.2174/0115734072492003260811045218.
    https://doi.org/10.2174/0115734072492003260811045218
  3. Kumar, A., & Verma, V. (2026). Mechanistic pharmacology of TCM-derived bioactive compounds in Alzheimer’s disease: Molecular targets, standardization, and translational insights. Pharmacological Research – Modern Chinese Medicine. DOI: 10.1016/j.prmcm.2026.100831.
    https://doi.org/10.1016/j.prmcm.2026.100831
  4. Verma, V., & Kumar, D. (2026). Theranostic applications of PSMA-targeted radiopharmaceuticals: From molecular design to clinical translation and emerging paradigms. Current Radiopharmaceuticals. DOI: 10.1016/j.craph.2026.100054.
    https://doi.org/10.1016/j.craph.2026.100054
  5. Verma, V., & Kumar, D. (2026). Quercetin and the gut-brain axis: Microbiome modulation, neuroprotection, and therapeutic implications. AIMS Molecular Science, 2026. DOI: 10.3934/molsci.2026012.
    https://doi.org/10.3934/molsci.2026012

Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Ms. Baby Rabiya Parveen | Pharmaceutical Chemistry | Best Researcher Award

Associate Professor, S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, India

Dr. Baby Rabiya Parveen is a dedicated researcher currently pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. With a Master’s in Pharmaceutical Chemistry and a Bachelor’s in Pharmacy, both from S.D. College of Pharmacy, her academic journey has been marked by excellence and a commitment to advancing pharmaceutical sciences. Her research interests span the synthesis of novel pharmaceutical compounds and their biological evaluations, contributing significantly to her field. 🌟

Publication Profile

ORCID

Strengths for the Award:

  1. Extensive Educational Background: Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry and holds both a Master’s and Bachelor’s degree in Pharmaceutical Chemistry with impressive academic performance.
  2. Diverse Workshop Participation: She has actively participated in numerous workshops and faculty development programs covering a wide range of topics relevant to pharmaceutical research, including intellectual property rights, drug regulatory affairs, and biotechnological applications.
  3. Research Contributions: Rabiya has contributed significantly to the field with multiple research papers on topics such as novel oxazine derivatives, antimicrobial agents, and drug synthesis. Her work on molecular docking and synthesis of new compounds demonstrates a strong commitment to advancing pharmaceutical science.
  4. Conference Presentations: She has presented her research at several national and international conferences, showcasing her work to a broader scientific audience and contributing to the dissemination of knowledge in the field.
  5. Industrial Experience: Her industrial training at Deepali Pharmaceuticals adds practical experience to her academic achievements, enhancing her understanding of real-world applications of her research.
  6. Book Chapters: Rabiya has contributed chapters to books on advanced topics like metallic nanoparticles and ghee standards, reflecting her expertise and ability to communicate complex concepts.

Areas for Improvement:

  1. Publication Record: While Rabiya has a commendable list of research papers, increasing the number of high-impact publications in top-tier journals could further strengthen her research profile.
  2. Research Impact: Demonstrating the practical impact of her research on pharmaceutical practice or policy could provide more evidence of her work’s significance.
  3. Collaborative Research: Engaging in collaborative projects with researchers from other institutions or industries might enhance the scope and applicability of her research.
  4. Grants and Funding: Securing research grants and funding could support more extensive studies and increase her visibility in the research community.

Education

Dr. Baby Rabiya Parveen is pursuing a PhD in Pharmaceutical Chemistry from IFTM University, Moradabad. She completed her Master of Pharmacy in Pharmaceutical Chemistry with honors from S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar, and her Bachelor of Pharmacy from the same institution. Her academic background also includes a high distinction in both Intermediate and High School studies. 📚

Experience

Dr. Parveen has gained practical experience through a 45-day industrial training at Deepali Pharmaceuticals, Muzaffarnagar, where she applied her theoretical knowledge to real-world pharmaceutical practices. This hands-on experience complements her extensive academic training and research work. 🏭

Research Focus

Dr. Parveen’s research primarily focuses on the synthesis of novel pharmaceutical compounds and their pharmacological activities. Her work includes the development of new oxazine derivatives, Schiff bases, and isoxazole compounds, with a keen interest in their anti-inflammatory, antimicrobial, and anxiolytic activities. Her research contributes to the development of new therapeutic agents. 🔬

Awards and Honours

Dr. Parveen has been recognized for her academic and research achievements through various awards and honors. Her contributions to pharmaceutical sciences have been acknowledged in multiple conferences and workshops, reflecting her commitment to advancing the field. 🏆

Publications

“Synthesis of some new 3-[5-(substituted-phenyl)-[1,3,4]oxadiazole-2-yl]-1-napthalen-2-yl-propan-1-one” – Published in [Journal Name, Year].

“Synthesis and Biological Evaluation of Some New Amide Derivatives of Sulfonamide” – Published in [Journal Name, Year].

“Synthesis and biological evaluation of some new Schiff base 1,2,4-Triazole Derivatives” – Published in [Journal Name, Year].

“A Short Review on Sulfonamides with Antimicrobial Activity” – Published in [Journal Name, Year].

“A Short Review on Synthesis and Pharmacological Activity of Isoxazole” – Published in [Journal Name, Year].

Conclusion:

Baby Rabiya Parveen is a strong candidate for the Research for Best Researcher Award due to her solid educational background, active participation in professional development, significant research contributions, and industrial experience. Her diverse expertise and dedication to advancing pharmaceutical sciences are commendable. Addressing the areas for improvement, particularly in increasing high-impact publications and demonstrating the practical impact of her research, could further solidify her position as a leading researcher in her field.